Press Releases

Stay up to date with the exciting new developments as we continue to grow.

Featured Press Release

Novel approach based on InVision® liquid biopsy platform predicts response to immune checkpoint inhibitors

​New peer-reviewed publication outlines an approach that identifies NSCLC patients who are most likely to respond to treatment with PD-1 ... read more

Inivata to Present New Clinical Data on the Utility of Liquid Biopsy and InVisionFirst®-Lung at World Conference on Lung Cancer 2019

Research Triangle Park, NC, USA and Cambridge, UK, August 29, 2019 — Inivata, a leader in liquid biopsy, is pleased to announce that the Company ... read more

Inivata appoints Jacqui Watson as Chief People Officer

Research Triangle Park, NC, USA and Cambridge, UK, August 12, 2019 — Inivata, a leader in liquid biopsy, is pleased to announce the appointment ... read more

Inivata announces launch of clinical trial to evaluate impact of InVisionFirst®-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer

Prospective, interventional study sponsored by Centre Léon Bérard cancer center will compare use of InVisionFirst-Lung versus standard of care ... read more

Inivata Signs Distribution Agreement with IPS Genomix for InVision® Genomic Tests in the Middle East and Africa

Research Triangle Park, NC, USA and Cambridge, UK, and Dubai, UAE , July 16, 2019 — Inivata, a leader in liquid biopsy, has signed a distribution read more

Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst-Lung liquid biopsy test

Inivata, a leader in liquid biopsy, today published the clinical validation results and real-world utility of its InVisionFirst-Lung liquid ... read more

Inivata Receives Accreditation from the College of American Pathologists (CAP)

CAP Accreditation is Awarded to Clinical Laboratories Meeting the Highest Standards in Laboratory Practices. Inivata, a leader in liquid biopsy, ... read more

Inivata, Thermo Fisher Scientific, and Genomics England successfully complete first phase of study assessing plasma samples and potential of liquid biopsy

Initial phase reveals high quality of samples through analysis using Inivata and Thermo Fisher Scientific’s liquid biopsy technologies Collection read more

Inivata Completes $52.6m (£39.8m) Series B Funding Round

Funds will accelerate commercialization of InVisionFirst-Lung Liquid Biopsy test and the development of the InVision® liquid biopsy platform into read more

Inivata Publishes Positive Results of Clinical Validation and Utility Study for InVision® Liquid Biopsy Test

Large, real-world, prospective study shows Inivata’s liquid biopsy test is able to provide molecular profile when tissue is unavailable and guide read more

Inivata Receives Medicare Final Coverage Decision for InVisionFirst-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer

Final Coverage Supports the Use of InVisionFirst-Lung for Aiding in the Management of Patients with Advanced NSCLC Inivata, a leader in liquid ... read more

Inivata appoints Charlie Kesinger as CIO

Inivata, a leader in liquid biopsy, today announces the appointment of Charlie Kesinger as Chief Information Officer.  Prior to joining Inivata, ... read more

Inivata to Present Results of Prospective Clinical Validation Study of its InVisionFirst-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer (NSCLC) at the World Conference on Lung Cancer

InVisionFirst-Lung testing demonstrates excellent concordance with standard of care tissue profiling and enables more complete profiling of ... read more

Inivata Achieves Major Milestone with Draft Medicare Local Coverage Determination (LCD) for InVisionFirst™-Lung Liquid Biopsy Test

Draft Coverage Supports the Use of InVisionFirst-Lung for Aiding in the Management of Patients withAdvanced Non-Small-Cell Lung Cancer Research ... read more

Michael Stocum to Step Down as Inivata CEO

Inivata, a global clinical cancer genomics company utilizing an industry-leading liquid biopsy platform to transform patient care announces that ... read more

Presentation of New Data on Inivata’s Industry-Leading Liquid Biopsy Platform at AACR 2018 Annual Meeting

Oral presentations and posters to feature Inivata’s InVision® liquid biopsy platform and its application Inivata, a global clinical cancer ... read more

Inivata Publishes Results of Analytical Validation for InVisionFirst-Lung ctDNA Liquid Biopsy

Publication support robustness and reproducibility of the InVision™ platform Industry-leading sensitivity and specificity shown across all ... read more

Inivata Announces Collaboration with MedStar Health to Utilize Liquid Biopsy to Advance Precision Cancer Genomics

MedStar and the MedStar Georgetown Cancer Institute to Join the Inivata Knowledge Accumulation Network (IKAN) Inivata, a global clinical cancer ... read more

Inivata to present at the Biotech Showcase in San Francisco

Company will also participate in “Generation Genome and Industrial Strategy: Leveraging UK Leadership in Genomics” Panel Inivata, a global ... read more

Inivata Announces Strategic Partnership with West Cancer Center

West Cancer Center joins the Inivata Knowledge Accumulation Network (IKAN) Inivata, a global clinical cancer genomics company utilizing an ... read more

Inivata Announces World-Leading SAB

Inivata, a global clinical cancer genomics company utilizing an industry-leading liquid biopsy platform to transform patient care, announces the ... read more

Inivata Highlights New Clinical Data on InVision™ ctDNA Liquid Biopsy Platform in advanced NSCLC at WCLC 2017

Inivata, a global clinical cancer genomics company utilizing an industry-leading liquid biopsy platform to transform patient care, today ... read more

Inivata Collaborates with Genomics England to Assess Samples and Explore Potential of Liquid Biopsy to Improve Cancer Management and Patient Outcomes

Pilot study to test Genomics England samples using Inivata’s InVisionTM platform Inivata, a global clinical cancer genomics company utilizing an ... read more

Addario Lung Cancer Medical Research Institute and Inivata Announce Major Study of ctDNA Analysis in Early Stage Lung Cancer

InVision™ ctDNA liquid biopsy platform to be used to inform therapy  following surgery of curative intent Addario Lung Cancer Medical Research ... read more

Inivata Announces Appointment of Dr Jamie Platt as Chief Operations Officer

Inivata, a global clinical cancer genomics company utilizing an industry-leading liquid biopsy platform to transform patient care, today ... read more

Inivata Announces Strategic Partnership with Levine Cancer Institute and Formation of the Inivata Knowledge Accumulation Network

 This network will bring together global leaders in cancer care to unlock the potential of liquid biopsy to improve patient outcomes Inivata, a ... read more

Inivata Highlights New Clinical Data on the InVision™ ctDNA Liquid Biopsy Platform in advanced NSCLC at ASCO 2017 Annual Meeting

Inivata Highlights New Clinical Data on the InVision™ ctDNA Liquid Biopsy Platform in advanced NSCLC at ASCO 2017 Annual Meeting Study shows ... read more

Inivata, in Collaboration with World-Leading Academic Centers, to Present Promising New Clinical Data on the Utility of the InVision™ ctDNA Platform across Multiple Tumor Types at ASCO 2017 Annual Meeting

Collaborative projects with leading cancer research centers highlight progress in development of Inivata’s InVision ctDNA liquid biopsy platform ... read more

Inivata to Present at AACR Annual Meeting 2017

Inivata, a global clinical cancer genomics company employing a revolutionary approach to circulating tumor DNA (ctDNA) analysis to improve ... read more

Inivata and Gustave Roussy Publish Positive Results from Prospective Clinical Study in use of ctDNA Liquid Biopsy to Guide Cancer Treatment

Publication in Annals of Oncology Shows Benefit of Osimertinib in EGFR-mutant Non-Small Cell Lung Cancer Patients with T790M-Mutation Detected by read more

New Review of ctDNA Liquid Biopsies in Nature Reviews Cancer Co-Authored by Inivata CSO Nitzan Rosenfeld

Inivata, a global clinical cancer genomics company employing a revolutionary approach to circulating tumor DNA (ctDNA) analysis to improve ... read more

Inivata is attending The Molecular Medicine Tri Conference Feb 19-24, San Francisco

Davina Gale, an Inivata co-founder and Business Development Manager is attending The Molecular Medicine Tri Conference Feb 19-24 in San ... read more

Inivata will host a session on liquid biopsy at PMWC January 23rd, 2017

We are excited to be hosting a session on liquid biopsy at the upcoming PMWC conference in Silicon Valley on January 23rd. Learn more about our ... read more

Inivata to Present at Biotech Showcase alongside the JP Morgan Conference

Inivata is excited to be attending the JP Morgan Healthcare Conference and presenting at the 9th Annual Biotech Showcase conference: both taking ... read more

Inivata and Gustave Roussy Presented Data at World Lung Conference Demonstrating the Clinical Use of Liquid Biopsy Approaches in Lung Cancer Patients when Tissue is Not Available

Inivata and Gustave Roussy Presented Data at World Lung Conference Demonstrating the Clinical Use of Liquid Biopsy Approaches in Lung Cancer ... read more

Inivata Wins One Nucleus BioNewsRound Award 2016 at Genesis Conference

Inivata Wins One Nucleus BioNewsRound Award 2016 at Genesis Conference  Inivata has been named as this year’s winner of the One Nucleus ... read more

Inivata in the News

Inivata has been in the news a lot recently!  Please see below two events which have prompted this coverage:  We have been nominated for the ... read more

Inivata and N-of-One Partner to Provide Personalized Genomic Interpretation and Clinical Trial Matching for Cancer Patients

Inivata and N-of-One Partner to Provide Personalized Genomic Interpretation and Clinical Trial Matching for Cancer Patients N-of-One to Identify ... read more

Inivata Launches US Clinical Trial of Innovative ctDNA Liquid Biopsy Analysis in Lung Cancer

Large-Scale, Prospective Clinical Validation Study to be Conducted with Vector Oncology Inivata, a global clinical cancer genomics company ... read more

Inivata Opens US CLIA Laboratory in Research Triangle Park

Inivata, a global clinical cancer genomics company employing the precision of circulating tumor DNA (ctDNA) analysis to improve personalized ... read more

Inivata Announces Appointment of Timothy Shannon as Chief Financial Officer

Inivata, a global clinical cancer genomics company employing the precision of circulating tumor DNA (ctDNA) analysis to improve personalized ... read more

Inivata Adds to Board of Directors with Appointment of Peter Wrighton-Smith

Inivata, a global clinical cancer genomics company employing the precision of circulating tumour DNA (ctDNA) analysis to improve personalised ... read more

Inivata Highlights its InVision ctDNA Assay for Broad Molecular Profiling and Presentation of NSCLC data at ASCO Annual Meeting 2016

Inivata Highlights its InVision™ ctDNA Assay for Broad Molecular Profiling and Presentation of NSCLC data at ASCO Annual Meeting 2016  Inivata, a read more

Inivata Boosts Executive Team with appointment of Clive Morris as Chief Medical Officer

Inivata, a global clinical cancer genomics company employing the precision of circulating tumour DNA (ctDNA) analysis to improve personalised ... read more

Inivata to present results of analytical validation at the AACR Annual Meeting 2016

Inivata, a global clinical cancer genomics company, will present performance data from the analytical validation of its enhanced TAm-SeqTM ... read more

Inivata Completes £31.5 Million ($45M) Series A Fundraising Round

Inivata Limited, a clinical cancer genomics company employing the precision of circulating tumour DNA (“ctDNA”) analysis to improve personalized ... read more

Inivata Expands Executive Leadership Team with the Appointment of James Clark as VP of Clinical Laboratory Operations

Inivata Limited, a clinical cancer genomics company focussed on harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve ... read more

CSO Nitzan Rosenfeld wins Foulkes Medal

Leading Cambridge scientist, genetics and cancer pioneer Dr Nitzan Rosenfeld, has won an internationally recognised honour – the coveted Foulkes ... read more

Inivata Strengthens Senior Leadership Ahead of Next Stage of Company Growth

Inivata, a leader in liquid biopsy, today announces the strengthening of its senior leadership team with the appointment of Clive Morris, ... read more

Inivata to Present New Clinical Data on the Utility of the InVision® Liquid Biopsy Platform in Advanced Non-Small Cell Lung Cancer (NSCLC) at WCLC 2018

Oral presentations and posters to feature Inivata’s InVisionFirst™ -Lung and the applications of liquid biopsy in Advanced Non-Small Cell Lung ... read more

What’s the need of having a 500 gene panel when you only have drugs for 7 targets? Heard at #LACLC19

Dr. Luis Raez focuses on new technologies for liquid biopsies. What’s coming next from a simple blood draw #LACLC19

What is happening with TMB? @drgandara is presenting results from different studies, excellent summary! #LACLC19